 Connection
Paul Bunn to Bone Marrow
This is a "connection" page, showing publications Paul Bunn has written about Bone Marrow.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.144 |
|
|
|
-
Johnson TK, Gonzalez R, Kasliwal RK, Lear JL, Feyerabend AJ, Dienhart DG, Ceriani RL, Bunn PA. Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy. Radiology. 1992 Jan; 182(1):107-14.
Score: 0.088
-
Foon KA, Schroff RW, Bunn PA. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma. Prog Clin Biol Res. 1986; 211:265-84.
Score: 0.015
-
Bunn PA, Krasnow S, Makuch RW, Schlam ML, Schechter GP. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood. 1982 Mar; 59(3):528-35.
Score: 0.011
-
Shackney SE, Bunn PA, Ford SS, Erickson B, Ross WE, Levine AS. A study of drug-induced kinetic perturbations in the marrow of a patient with neuroblastoma. Cancer. 1980 Mar 01; 45(5):882-92.
Score: 0.010
-
Shackney SE, Bunn PA, Ford SS. The effects of colcemid on mouse bone marrow. Cell Tissue Kinet. 1976 Jul; 9(4):363-9.
Score: 0.008
-
Jaffe ES, Blattner WA, Blayney DW, Bunn PA, Cossman J, Robert-Guroff M, Gallo RC. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984 Apr; 8(4):263-75.
Score: 0.003
-
Minna JD, Cuttitta F, Rosen S, Bunn PA, Carney DN, Gazdar AF, Krasnow S. Methods for production of monoclonal antibodies with specificity for human lung cancer cells. In Vitro. 1981 Dec; 17(12):1058-70.
Score: 0.003
-
Nugent JL, Bunn PA, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer. 1979 Nov; 44(5):1885-93.
Score: 0.002
-
Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):575-80.
Score: 0.002
-
Ihde DC, Cohen MH, Bunn PA, Bernath AM, Broder LE, Minna JD. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity. Cancer Treat Rep. 1978 Jan; 62(1):155-7.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|